Efgartigimod alfa. Neonatal Fc receptor (FcRn) antagonist, Treatment of generalized myasthenia gravis, Treatment of primary immune thrombocytopenia, Treatment of pemphigus vulgaris and foliaceous, Treatment of chronic inflammatory demyelinating polyneuropathy
2006 ◽
Vol 240
(1-2)
◽
pp. 103-106
◽
2009 ◽
Vol 106
(12)
◽
pp. 4788-4792
◽
2017 ◽
Vol 128
(6)
◽
pp. 570-572
◽
1999 ◽
Vol 14
(7)
◽
pp. 478-479
◽
1996 ◽
Vol 3
(4)
◽
pp. 397-398
◽
2016 ◽
Vol 24
(4)
◽
pp. 223-231
◽